Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Evidence Regarding Medication Overuse Headache in Children and Adolescents: Protocol for a Systematic Review.

VanderPluym J, Gautreaux J, Burch R, Whitaker E, Roberts J, Turner DP, Gelfand AA.

Headache. 2020 Jan;60(1):171-177. doi: 10.1111/head.13726.

PMID:
31913513
2.

Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline.

Evans RW, Burch RC, Frishberg BM, Marmura MJ, Mechtler LL, Silberstein SD, Turner DP.

Headache. 2019 Dec 31. doi: 10.1111/head.13720. [Epub ahead of print]

PMID:
31891197
3.

Underrepresentation of Women Among Authors of Invited Commentaries in Medical Journals-Where Are the Female Editorialists?

Loder E, Burch R.

JAMA Netw Open. 2019 Oct 2;2(10):e1913665. doi: 10.1001/jamanetworkopen.2019.13665. No abstract available.

PMID:
31642923
4.

Epidemiology and Treatment of Menstrual Migraine and Migraine During Pregnancy and Lactation: A Narrative Review.

Burch R.

Headache. 2020 Jan;60(1):200-216. doi: 10.1111/head.13665. Epub 2019 Oct 3. Review.

PMID:
31579938
5.

Migraine: Epidemiology, Burden, and Comorbidity.

Burch RC, Buse DC, Lipton RB.

Neurol Clin. 2019 Nov;37(4):631-649. doi: 10.1016/j.ncl.2019.06.001. Epub 2019 Aug 27. Review.

PMID:
31563224
6.

Eleven Things Not to Say to Your Female Colleagues.

Borrero-Mejias C, Starling AJ, Burch R, Loder E; Migraine Mavens Writing Consortium.

Headache. 2019 Nov;59(10):1846-1854. doi: 10.1111/head.13647. Epub 2019 Sep 26. No abstract available.

PMID:
31557320
7.

Closing the Wearable Gap-Part II: Sensor Orientation and Placement for Foot and Ankle Joint Kinematic Measurements.

Saucier D, Luczak T, Nguyen P, Davarzani S, Peranich P, Ball JE, Burch RF 5th, Smith BK, Chander H, Knight A, Prabhu RK.

Sensors (Basel). 2019 Aug 10;19(16). pii: E3509. doi: 10.3390/s19163509.

8.

An assay for screening xenobiotics for inhibition of rat thyroid gland peroxidase activity.

Price RJ, Burch R, Chatham LR, Higgins LG, Currie RA, Lake BG.

Xenobiotica. 2020 Mar;50(3):318-322. doi: 10.1080/00498254.2019.1629044. Epub 2019 Jun 19.

PMID:
31180273
9.

Antidepressants for Preventive Treatment of Migraine.

Burch R.

Curr Treat Options Neurol. 2019 Mar 21;21(4):18. doi: 10.1007/s11940-019-0557-2. Review.

PMID:
30895388
10.

Regional Anesthesia in the Combat Setting: Are ACGME Requirements Enough?

Dhanjal ST, Highland KB, Nguyen DM, Santos DM, Burch RH, Maani CV, Aden JK, Patel R, Buckenmaier CC.

Mil Med. 2019 Dec 1;184(11-12):745-749. doi: 10.1093/milmed/usz007.

PMID:
30793205
11.

Migraine and Tension-Type Headache: Diagnosis and Treatment.

Burch R.

Med Clin North Am. 2019 Mar;103(2):215-233. doi: 10.1016/j.mcna.2018.10.003. Epub 2018 Dec 3. Review.

PMID:
30704678
12.

Consideration of Costs and Open-Label Studies of Erenumab-Reply.

Loder EW, Burch RC.

JAMA Neurol. 2019 Feb 1;76(2):236-237. doi: 10.1001/jamaneurol.2018.4141. No abstract available.

PMID:
30575855
13.

Headache in Pregnancy and the Puerperium.

Burch R.

Neurol Clin. 2019 Feb;37(1):31-51. doi: 10.1016/j.ncl.2018.09.004. Review.

PMID:
30470274
14.

Safety Problems With a Transdermal Patch for Migraine: Lessons From the Development, Approval, and Marketing Process.

Loder EW, Rayhill M, Burch RC.

Headache. 2018 Nov;58(10):1639-1657. doi: 10.1111/head.13424. Epub 2018 Oct 27.

PMID:
30367818
15.

Episodic Migraine With and Without Aura: Key Differences and Implications for Pathophysiology, Management, and Assessing Risks.

Vgontzas A, Burch R.

Curr Pain Headache Rep. 2018 Oct 5;22(12):78. doi: 10.1007/s11916-018-0735-z. Review.

PMID:
30291554
16.

New preventive treatments for migraine.

Burch R, Rayhill M.

BMJ. 2018 Jun 13;361:k2507. doi: 10.1136/bmj.k2507. No abstract available.

PMID:
29899031
17.

Who Should Try New Antibody Treatments for Migraine?

Loder EW, Burch RC.

JAMA Neurol. 2018 Sep 1;75(9):1039-1040. doi: 10.1001/jamaneurol.2018.1268. No abstract available.

PMID:
29799961
18.

The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies.

Burch R, Rizzoli P, Loder E.

Headache. 2018 Apr;58(4):496-505. doi: 10.1111/head.13281. Epub 2018 Mar 12.

PMID:
29527677
19.

Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder.

Linkovski O, Shen H, Zwerling J, Filippou-Frye M, Jo B, Cordell E, Cooper TB, Simpson HB, Burch RM, Moskal JR, Lee F, Rodriguez CI.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 17l11824. doi: 10.4088/JCP.17l11824. No abstract available.

20.

Papilledema in Idiopathic Intracranial Hypertension.

Vgontzas A, Prasad S, Burch RC.

Headache. 2018 Apr;58(4):579-580. doi: 10.1111/head.13271. Epub 2018 Feb 5. No abstract available.

PMID:
29399792
21.

Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.

Zlatic SA, Vrailas-Mortimer A, Gokhale A, Carey LJ, Scott E, Burch R, McCall MM, Rudin-Rush S, Davis JB, Hartwig C, Werner E, Li L, Petris M, Faundez V.

Cell Syst. 2018 Mar 28;6(3):368-380.e6. doi: 10.1016/j.cels.2018.01.008. Epub 2018 Jan 31.

22.

Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review.

Sheikh HU, Pavlovic J, Loder E, Burch R.

Headache. 2018 Jan;58(1):5-21. doi: 10.1111/head.13229. Epub 2017 Nov 15.

PMID:
29139115
23.

Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison.

Shamseer L, Moher D, Maduekwe O, Turner L, Barbour V, Burch R, Clark J, Galipeau J, Roberts J, Shea BJ.

BMC Med. 2017 Mar 16;15(1):28. doi: 10.1186/s12916-017-0785-9.

24.

PFO and Migraine: Is There a Role for Closure?

Rayhill M, Burch R.

Curr Neurol Neurosci Rep. 2017 Mar;17(3):20. doi: 10.1007/s11910-017-0730-5. Review.

PMID:
28283958
25.

Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept.

Rodriguez CI, Zwerling J, Kalanthroff E, Shen H, Filippou M, Jo B, Simpson HB, Burch RM, Moskal JR.

Am J Psychiatry. 2016 Dec 1;173(12):1239-1241. No abstract available.

26.

Application of novel catalysts: general discussion.

Miller AL, Bowker M, García-Trenco A, Socci J, Richards N, Hutchings G, Collis N, Earley J, Freakley S, Burch R, Howard M, Gross E, Kotarba A, Landau MV, Anderson J, Weckhuysen B, Kondrat S, Naranov E, Douthwaite JM, Tiruvalam R, Iqbal S, Parker L, Shah P, Nowicka E, Ueda W, Piovano A, Landon P, Fischer N, Reece C, Gates B, Lamb M, Jackman E, Jakubek T, Corma A, Claeys M, Svengren H, Friend C, Lennon D, Makepeace J, Hunter H, Manyar H.

Faraday Discuss. 2016 Jul 4;188:399-426. doi: 10.1039/C6FD90018F. No abstract available.

PMID:
27328423
27.

Designing new catalysts: synthesis of new active structures: general discussion.

Selvam P, Sauer J, Garrett B, Campbell C, van Santen R, Davies P, Miller AL, Bowker M, Hutchings G, Wotton D, Freund HJ, Howard M, Feaviour M, Burch R, Raspolli Galletti AM, Gross E, Ivars Barcelo F, Kotarba A, Kondrat S, Weckhuysen B, Majumdar B, Bruix A, Fischer N, Gates B, Moulijn J, Roldan A, Novak Tusar N, Jakubek T, Willock D, Craven M, Sethu K, Catlow R, Madix R, Manyar H, Friend C, Corma A, Wells P, Ueda W, Trunschke A, Palmer R.

Faraday Discuss. 2016 Jul 4;188:131-59. doi: 10.1039/C6FD90015A. No abstract available.

PMID:
27328021
28.

Migraine and vascular disease.

Burch RC, Rayhill ML.

BMJ. 2016 May 31;353:i2806. doi: 10.1136/bmj.i2806. No abstract available.

PMID:
27247290
29.

The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant.

Moskal JR, Burgdorf JS, Stanton PK, Kroes RA, Disterhoft JF, Burch RM, Khan MA.

Curr Neuropharmacol. 2017;15(1):47-56. Review.

30.

Registration status and outcome reporting of trials published in core headache medicine journals.

Rayhill ML, Sharon R, Burch R, Loder E.

Neurology. 2015 Nov 17;85(20):1789-94. doi: 10.1212/WNL.0000000000002127. Epub 2015 Oct 16. Review.

PMID:
26475691
31.

The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.

Burgdorf J, Zhang XL, Weiss C, Gross A, Boikess SR, Kroes RA, Khan MA, Burch RM, Rex CS, Disterhoft JF, Stanton PK, Moskal JR.

Neuroscience. 2015 Nov 12;308:202-11. doi: 10.1016/j.neuroscience.2015.09.004. Epub 2015 Sep 4.

32.

Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.

Burgdorf J, Kroes RA, Zhang XL, Gross AL, Schmidt M, Weiss C, Disterhoft JF, Burch RM, Stanton PK, Moskal JR.

Behav Brain Res. 2015 Nov 1;294:177-85. doi: 10.1016/j.bbr.2015.07.039. Epub 2015 Jul 22.

33.

Evaluating change in user error when using ruggedized handheld devices.

Cannon AB, Strawderman L, Burch R.

Appl Ergon. 2015 Nov;51:273-80. doi: 10.1016/j.apergo.2015.05.001. Epub 2015 Jun 11.

PMID:
26154226
34.

Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent.

Preskorn S, Macaluso M, Mehra DO, Zammit G, Moskal JR, Burch RM; GLYX-13 Clinical Study Group.

J Psychiatr Pract. 2015 Mar;21(2):140-9. doi: 10.1097/01.pra.0000462606.17725.93.

PMID:
25782764
35.

The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.

Burch RC, Loder S, Loder E, Smitherman TA.

Headache. 2015 Jan;55(1):21-34. doi: 10.1111/head.12482. Review. Erratum in: Headache. 2015 Feb;55(2):356.

PMID:
25600719
36.

Meditation for migraines: a pilot randomized controlled trial.

Wells RE, Burch R, Paulsen RH, Wayne PM, Houle TT, Loder E.

Headache. 2014 Oct;54(9):1484-95. doi: 10.1111/head.12420. Epub 2014 Jul 18.

PMID:
25041058
37.

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists.

Moskal JR, Burch R, Burgdorf JS, Kroes RA, Stanton PK, Disterhoft JF, Leander JD.

Expert Opin Investig Drugs. 2014 Feb;23(2):243-54. doi: 10.1517/13543784.2014.852536. Epub 2013 Nov 20. Review.

38.

Measurement of the plasma astrophysical S factor for the 3He(d,p)4He reaction in exploding molecular clusters.

Barbui M, Bang W, Bonasera A, Hagel K, Schmidt K, Natowitz JB, Burch R, Giuliani G, Barbarino M, Zheng H, Dyer G, Quevedo HJ, Gaul E, Bernstein AC, Donovan M, Kimura S, Mazzocco M, Consoli F, De Angelis R, Andreoli P, Ditmire T.

Phys Rev Lett. 2013 Aug 23;111(8):082502. Epub 2013 Aug 22.

PMID:
24010431
39.

What can data mining teach us about triptan safety that we don't already know?

Loder E, Burch R.

Cephalalgia. 2014 Jan;34(1):3-4. doi: 10.1177/0333102413499647. Epub 2013 Aug 5. No abstract available.

PMID:
23918835
40.

Pathophysiology of migraine.

Burch R, Wells R.

Headache. 2013 Feb;53(2):420-2. No abstract available.

PMID:
23560278
41.

An in situ spatially resolved analytical technique to simultaneously probe gas phase reactions and temperature within the packed bed of a plug flow reactor.

Touitou J, Burch R, Hardacre C, McManus C, Morgan K, Sá J, Goguet A.

Analyst. 2013 May 21;138(10):2858-62. doi: 10.1039/c3an00250k.

PMID:
23552570
42.

The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.

Smitherman TA, Burch R, Sheikh H, Loder E.

Headache. 2013 Mar;53(3):427-36. doi: 10.1111/head.12074. Epub 2013 Mar 7. Review.

PMID:
23470015
43.

Headache Currents Commentary.

Burch R.

Headache. 2013 Jan;53(1):E1. doi: 10.1111/head.12021. Epub 2012 Dec 20. No abstract available.

PMID:
23278836
44.

Migraine and risk of incident diabetes in women: a prospective study.

Burch RC, Rist PM, Winter AC, Buring JE, Pradhan AD, Loder EW, Kurth T.

Cephalalgia. 2012 Oct;32(13):991-7. Epub 2012 Jul 17.

45.

The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines.

Loder E, Burch R, Rizzoli P.

Headache. 2012 Jun;52(6):930-45. doi: 10.1111/j.1526-4610.2012.02185.x.

PMID:
22671714
46.

Measuring pain intensity in headache trials: which scale to use?

Loder E, Burch R.

Cephalalgia. 2012 Feb;32(3):179-82. doi: 10.1177/0333102411434812. Epub 2012 Jan 27. No abstract available.

PMID:
22287565
47.

New insight into mechanisms in water-gas-shift reaction on Au/CeO2(111): a density functional theory and kinetic study.

Chen Y, Wang H, Burch R, Hardacre C, Hu P.

Faraday Discuss. 2011;152:121-33; discussion 203-25.

PMID:
22455041
48.

Bridging the gap between CO adsorption studies on gold model surfaces and supported nanoparticles.

López-Haro M, Delgado JJ, Cies JM, del Rio E, Bernal S, Burch R, Cauqui MA, Trasobares S, Pérez-Omil JA, Bayle-Guillemaud P, Calvino JJ.

Angew Chem Int Ed Engl. 2010 Mar 8;49(11):1981-5. doi: 10.1002/anie.200903403. No abstract available.

PMID:
20186893
49.

The progress of humane experimental technique since 1959: a personal view.

Burch RL.

Altern Lab Anim. 2009 Jul;37(3):269-75.

PMID:
19678728
50.

Prefatory Note.

Russell WM, Burch RL.

Altern Lab Anim. 2009 Jul;37(3):267-8. No abstract available.

PMID:
19678727

Supplemental Content

Support Center